ESMO Media Releases

A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle. 

An important new study has revealed the clearest picture yet of precisely how much measurement variation influences gene expression profiles of breast cancer.

Breast cancers contain many different cell types with different patterns of gene expression, but a new study provides reassurance that this variability should not be a barrier to using gene expression tests to help tailor cancer treatments to individual patients.

Highlighting the need for more in-depth education and wider collaborations between researchers, oncologists and patients.

It’s time cinema directors realised cancer isn’t always a death sentence, a new study shows

ESMO 2012 emphasises palliative care: 16 new ESMO Designated Centres of Integrated Oncology and Palliative Care honoured New research providing snap-shot of palliative care in Italy

The first ever estimate of the economic burden of cancer in Europe shows that it exceeds 124 billion euros

Studies presented at ESMO 2012 highlight challenges of cancer prevention

Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer, EGFR status may help select patients who will benefit most

Promising new data from trials aimed at delaying resistance to BRAF inhibitors